Aesthetic Practice Biologics Distributor in Fresno, CA

Vendor review inside medspas and aesthetic practices

A medspa operating under physician supervision, or a dermatology or aesthetic surgery practice, typically brings a new biologics supplier to the supervising physician before any order is placed, since the account has to be tied to that physician's license rather than to the practice as a business. Many of these practices also look closely at how a supplier describes its own products before bringing a vendor forward, including whether a Wharton's jelly or exosome product is marketed with any disease, condition, or outcome claim, which is a signal worth flagging to the medical director regardless of supplier.

NPI verification before ordering

Ordering access and pricing are released only after the supervising physician's NPI has been verified against the NPPES registry, the same step required of every Precision Biologics account regardless of practice type or location. This keeps pricing off any public page and limits ordering to licensed professionals.

Shipping to aesthetic practices on the West Coast

Cryopreserved Wharton's jelly products ship overnight on dry ice in validated containers and need to move into -80 degree C storage without delay once they arrive, which practices with a full appointment calendar should plan staffing around in advance. Lyophilized formats, including freeze-dried exosome products, are described by the supplier as shelf-stable under normal storage, which gives lower-volume Fresno practices more flexibility for routine ordering between larger cryopreserved shipments.

Getting documentation and setting up an account

Every lot ships with a certificate of analysis, donor eligibility summary, and lot release record, and a peer-to-peer call is available to walk a medical director through that paperwork specifically. Aesthetic and dermatology practices should independently confirm licensure and supervision requirements with the Medical Board of California and their own counsel, since Precision Biologics does not advise on intended use or clinical protocols. Account setup support is available once NPI verification is complete.

FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.

These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.